Streetbeat News

Stock Prices

ATS

ATS shares have declined following Goldman Sachs' initiation of coverage with a Sell rating and a price target of $34.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 4:51 pm

NARI

Inari Medical's stock is trading higher following the announcement that it will be included in the S&P SmallCap 600 index. This inclusion is often viewed positively as it reflects the company's growth and stability, and can lead to increased demand for the stock from funds that track the index.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 4:50 pm

CRPT

MSTR

MVPA

MicroStrategy Inc (NASDAQ:MSTR) has launched MicroStrategy AutoTM, an AI-powered bot aimed at enhancing business intelligence (BI) delivery. This bot, part of the MicroStrategy AITM update, allows for customizable, user-friendly analytics through natural language interactions. It can be integrated into third-party apps or function independently within the MicroStrategy ONE library. The launch aims to improve decision-making and productivity by simplifying access to analytics. MSTR's stock has seen a 677% increase over the past year, attributed to the Bitcoin rally. Exposure to MSTR stock is also possible through First Trust SkyBridge Crypto Industry And Digital Economy ETF (NYSE:CRPT) and Advisor Managed Portfolios Miller Value Partners Appreciation ETF (NYSE:MVPA).

Portfolio Pulse from Anusuya Lahiri

March 26, 2024 | 4:50 pm

MESO

The FDA has informed Mesoblast Limited (NASDAQ:MESO) that the clinical data from its Phase 3 study MSB-GVHD001 is sufficient to support a BLA submission for remestemcel-L for pediatric SR-aGVHD. Mesoblast plans to file the resubmission next quarter. This follows a complete response letter from the FDA in August 2023 requiring more data. The FDA had previously supported an accelerated approval pathway for another of Mesoblast's products. MESO shares surged 75.90% to $3.87.

Portfolio Pulse from Vandana Singh

March 26, 2024 | 4:47 pm

NEM

Significant bearish options activity has been detected for Newmont (NYSE:NEM), with a total of 12 unusual trades. The sentiment is 100% bearish, with puts and calls indicating a price target range of $31.0 to $42.5. Newmont, the world's largest gold miner, has recently acquired Newcrest, planning to sell higher cost mines. The stock is currently up 0.94% at $34.24, with an analyst from Scotiabank setting a target price of $43.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 4:45 pm

CVX

Chevron (NYSE:CVX) has seen a mix of bullish and bearish options activity, with 10 unusual trades analyzed. The activity suggests a target price range of $150.0 to $162.5. Notable trades include both calls and puts with varying sentiments and expiration dates. Chevron, a major integrated energy company, has a current stock price of $156.61, with analysts from Piper Sandler and Mizuho issuing target prices of $180 and $200, respectively.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 4:45 pm

RFV

RWK

SNX

TD SYNNEX Corporation (NYSE:SNX) shares rose over 5% after reporting Q1 earnings per share of $2.99, surpassing expectations of $2.84, despite revenue of $13.975 billion missing forecasts of $14.357 billion. The company announced a $2 billion share repurchase program and a quarterly dividend of $0.40 per share. For Q2, it expects revenues between $13.3 billion and $14.9 billion, with adjusted EPS of $2.50-$3.00. SNX stock has gained 20% in the past year.

Portfolio Pulse from Nabaparna Bhattacharya

March 26, 2024 | 4:44 pm

CVNA

Carvana's stock is trading higher after Evercore ISI Group maintained an In-Line rating but increased the price target from $68 to $75.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 4:42 pm

ABOS

Acumen Pharmaceuticals shares dropped following the announcement of their Q4 earnings per share (EPS) results, which fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 4:41 pm

ALAB

Astera Labs' stock is experiencing a decline due to volatility following its recent Initial Public Offering (IPO).

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 4:40 pm